Why the study?
Can endocavitary structures be safely and successfully targeted during ventricular tachycardia ablation procedures?
Can endocavitary structures be safely and successfully targeted during ventricular tachycardia ablation procedures?
Endocavitary structures should be considered for specific mapping and can be safely targeted during VT ablation without causing valve damage.
Answers are grounded in this paper and cite their sources.
Endocavitary ablation may be considered in VT; leaves open need for prospective validation before practice change.
During VT ablation procedures, ECS should be considered for specific mapping and targeted ablation. Once recognized, these structures can be successfully targeted for ablation without valve damage.
No takes yet. Share an insight, caveat, or question.
AbouEzzeddine et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: